Search Results - "Danis, Kate"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non–Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers by Badman, Michael K., Chen, Jin, Desai, Sachin, Vaidya, Soniya, Neelakantham, Srikanth, Zhang, Jie, Gan, Lu, Danis, Kate, Laffitte, Bryan, Klickstein, Lloyd B.

    Published in Clinical pharmacology in drug development (01-04-2020)
    “…Tropifexor (LJN452) is a potent, orally available, non–bile acid farnesoid X receptor agonist under clinical development for chronic liver diseases. Here, we…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin by Yan, Jing-He, Meyers, Dan, Lee, Zachary, Danis, Kate, Neelakantham, Srikanth, Majumdar, Tapan, Rebello, Sam, Sunkara, Gangadhar, Chen, Jin

    Published in Journal of clinical pharmacology (01-07-2014)
    “…Pradigastat, a novel diacylglycerol acyltransferase‐1 inhibitor, was evaluated for both pharmacokinetic (PK) and pharmacodynamic (PD) drug–drug interactions…”
    Get full text
    Journal Article